BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2021

Mar 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2021-03-04

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-04	Common Stock	L	100	$77.94	Acquired	295652	Direct
2021-03-11	Common Stock	M	7000	$26.49	Acquired	302652	Direct
2021-03-11	Common Stock	S	7000	$77.68	Disposed	295652	Direct
2021-03-12	Common Stock	M	7000	$26.49	Acquired	302652	Direct
2021-03-12	Common Stock	S	7000	$77.10	Disposed	295652	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-11	Stock Option (Right to buy Common Stock)	$26.49	M	7000	Disposed	2021-05-11	Common Stock (7000)	Direct
2021-03-12	Stock Option (Right to buy Common Stock)	$26.49	M	7000	Disposed	2021-05-11	Common Stock (7000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	247533	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.

F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.